Literature DB >> 22821423

C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma.

Karen M F Sze1, Glanice K Y Chu, Joyce M F Lee, Irene O L Ng.   

Abstract

UNLABELLED: Random integration of hepatitis B virus (HBV) DNA into the host genome is frequent in human hepatocellular carcinoma (HCC) and this leads to truncation of the HBV DNA, particularly at the C-terminal end of the HBV X protein (HBx). In this study, we investigated the frequency of this natural C-terminal truncation of HBx in human HCCs and its functional significance. In 50 HBV-positive patients with HCC, full-length HBx was detected in all nontumorous livers. However, full-length HBx was found in only 27 (54%) of the HCC tumors, whereas natural carboxylic acid (COOH)-truncated HBx was found in the remaining 23 (46%) tumors. Upon clinicopathological analysis, the presence of natural COOH-truncated HBx significantly correlated with the presence of venous invasion, a hallmark of metastasis (P = 0.005). Inducible stable expression of the COOH-truncated HBx protein (with 24 amino acids truncated at the C-terminal end) enhanced the cell-invasive ability of HepG2 cells, as compared to full-length HBx, using the Matrigel cell-invasion assay. It also resulted in increased C-Jun transcriptional activity and enhanced transcription of matrix metalloproteinase 10 (MMP10), whereas activation of the MMP10 promoter by COOH-truncated HBx was abolished when the activator protein 1-binding sites on the MMP10 promoter were mutated. Furthermore, silencing of MMP10 by short interfering RNA in HBxΔC1-expressing HepG2 cells resulted in significant reduction of cell invasiveness.
CONCLUSIONS: Our data suggest that COOH truncation of HBx, particularly with 24 amino acids truncated at the C-terminal end, plays a role in enhancing cell invasiveness and metastasis in HCC by activating MMP10 through C-Jun.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22821423     DOI: 10.1002/hep.25979

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  61 in total

Review 1.  Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.

Authors:  Renumathy Dhanasekaran; Jean-Charles Nault; Lewis R Roberts; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2018-11-04       Impact factor: 22.682

2.  Up-regulation of IL-12 expression in patients with chronic hepatitis B is mediated by the PI3K/Akt pathway.

Authors:  Hong-wei Wang; Hai-li Gao; Xiao-xia Wei; Xin-hong Wang
Journal:  Mol Cell Biochem       Date:  2015-06-11       Impact factor: 3.396

3.  Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.

Authors:  G X Feng; J Li; Z Yang; S Q Zhang; Y X Liu; W Y Zhang; L H Ye; X D Zhang
Journal:  Oncogene       Date:  2017-08-28       Impact factor: 9.867

4.  Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma.

Authors:  Shenghua Hao; Ping Fan; Shaofei Chen; Caixue Tu; Chidan Wan
Journal:  J Gastrointest Surg       Date:  2016-11-04       Impact factor: 3.452

5.  Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis.

Authors:  Yongdong Niu; Meishu Xu; Betty L Slagle; Haihua Huang; Song Li; Grace L Guo; Ganggang Shi; Wenxin Qin; Wen Xie
Journal:  Hepatology       Date:  2017-01-19       Impact factor: 17.425

Review 6.  Cancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesis.

Authors:  W B Liu; J F Wu; Y Du; G W Cao
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

Review 7.  Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.

Authors:  Amy P Chiu; Barbara R Tschida; Lilian H Lo; Branden S Moriarity; Dewi K Rowlands; David A Largaespada; Vincent W Keng
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

8.  X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma.

Authors:  Ying Xie; Shufeng Liu; Yue Zhao; Zhanjun Guo; Jinsheng Xu
Journal:  Tumour Biol       Date:  2014-07-19

Review 9.  Role of hepatitis B virus DNA integration in human hepatocarcinogenesis.

Authors:  Hoang Hai; Akihiro Tamori; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

10.  Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects.

Authors:  Yan Du; Xue Han; Yi-Bo Ding; Jian-Hua Yin; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.